Breadcrumb

  1. Our vision
  2. About Santen
  3. Santen facts and figures

Santen facts and figures

€1.823 billion

€1.823 billion revenue (FY 2018) (approximately 234.0 billion yen)

92.3% of revenue from prescription ophthalmic pharmaceuticals

92.3% of revenue from prescription ophthalmic pharmaceuticals

Overseas sales accounts for 31.5%

Overseas sales accounts for 31.5% of corporate revenue (FY 2018)

#1 in Japanese prescription ophthalmic pharmaceuticals

#1 in Japanese prescription ophthalmic pharmaceuticals

Over 4,070+ employees globally

Over 4,070+ employees globally

Dedicated facility for ongoing research and development

Dedicated facilities for ongoing research and development: Nara Research and Development Centre (Japan), Evry (France), Emeryville, Miami and Goleta (US)

Products supplied in over 60 countries

Products supplied in over 60 countries

Six manufacturing sites

Six manufacturing sites: Noto and Shiga (Japan), Suzhou (China), Tampere (Finland), Miami and Goleta (US)